2020
DIGESTIVE AND LIVER DISEASE

GLP-2 analog teduglutide in active Crohn's disease and short bowel syndrome: confirmation of anti-inflammatory role and future perspectives

01 Pubblicazione su rivista
Borghini R., Caronna R., Donato G., Picarelli A.
ISSN: 1590-8658

no abstract available

anti-inflammatory treatment glucagon-like peptide (GLP) 2 malabsorption Parenteral Nutrition short bowel syndrome (SBS) teduglutide

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma